uncommon

Airna

This company develops RNA editing therapeutics to treat patients with rare genetic and common cardiometabolic diseases.

Noara Therapeutics

This company engineers stable and immunosilent ribonucleic acid therapies using machine intelligence to treat patients with chronic and complex diseases.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

Fork & Good

This company produces cultivated pork products for the food industry and consumers to provide sustainable protein alternatives.

Kerna

This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Laverock

This company develops programmable gene silencing and cell engineering platforms for healthcare providers and biotechnology partners to create disease-responsive advanced therapies.

Code Bio

This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.